CN1140332C - Conjugate linoleic acid or conjugate linoleate microcapsule - Google Patents
Conjugate linoleic acid or conjugate linoleate microcapsule Download PDFInfo
- Publication number
- CN1140332C CN1140332C CNB011413905A CN01141390A CN1140332C CN 1140332 C CN1140332 C CN 1140332C CN B011413905 A CNB011413905 A CN B011413905A CN 01141390 A CN01141390 A CN 01141390A CN 1140332 C CN1140332 C CN 1140332C
- Authority
- CN
- China
- Prior art keywords
- cla
- ester
- microcapsules
- wall material
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
The present invention relates to a microcapsule of conjugated linoleic acid or conjugated linoleic acid ester, which is composed of a wall material, a capsule core, an auxiliary agent, a surface active agent and a plasticizing agent, wherein the capsule core is added to the water solution of the wall material, and the auxiliary agent, the surface active agent and the plasticizing agent are simultaneously added to the water solution for emulsification; then, a microcapsule product is made by a spray drying process. A great number of experiments prove that the product has the advantages of enhancing antioxygenic property, enhancing storage stability, masking bad abnormal smell and odor, avoiding the mutual influence of unmatched components in food with a plurality of components and reducing the generation of degradation reaction to reach the purpose of controlling release; the product is made into dry solid powder so as to be easier for storage, transportation and addition. The microcapsule can be used for health food, food additives and feed additives; moreover, the microcapsule has the functions for resisting cancers and atherosclerosis, regulating and controlling metabolism, enhancing the immunity of a body, relieving the side reaction of an immune system, regulating blood sugar, resisting diabetes, promoting animal's growth and development, etc.
Description
Technical field
The present invention relates to a kind of microcapsules with spray drying method for preparation CLA or conjugate linoleate
Background technology
Microcapsules technology (microencapsulation) is a current new technology that develops rapidly, be meant with wall material (coating) material food composition or food additives embeddings such as the capsule heart (core) material such as grease, spices, flavouring, make it isolated, discharge again in due course with external environment.
Up to now, the method for microencapsulation can be divided into three major types: 1, the applied chemistry principle prepares the method for microcapsules, as interfacial polymerization, situ aggregation method etc.; 2, the Applied Physics principles of chemistry prepare the method for microcapsules, as single coacervation, complex coacervation, oil-phase separating method etc.; 3, Applied Physics and theory of mechanics prepare the method for microcapsules, as pot bag method, spray-on process, porous centrifugal process etc.
CLA (Conjugated Linoleic Acid) is the mixture that contains a series of octadecadienoic acids of conjugated double bond, and these octadecadienoic acids exist configuration and conformation different isomers as 9-c, 11-c; 10-c, 12-c; 9-t, 11-t; 10-t, 12-t; 9-t, 11-c; 9-c, 11-t; 10-c, 12-t; 10-t, 12-c; In French cheese, found 8,10 and 11,13 isomers afterwards again.
Up to the present, discover 9-c, 11-t and 10-t, 12-c are two kinds of maximum isomers of content in the CLA, and its chemical formula is:
The ester of CLA is meant that CLA and alcohols, phenols or other material that contains hydroxyl generate the product that contains ester group.
Through a large amount of animal and human research's evidence, CLA and ester thereof have anticancer, antiatherosclerosis, and the regulation and control metabolism increases muscle, reduces fat, strengthens immunity of organisms, slows down the immune system side reaction; Regulate blood sugar, anti-diabetic; Effect such as promote to grow.Can be widely used in fields such as health food, food additives, feed addictive.But because CLA and derivative thereof and easily oxidized bring very big inconvenience to its use.
According to data from abroad, the report of the microencapsulation of unrighted acid and grease much for example:
It is the wall material that U.S. Pat 5601760 has prepared with the lactalbumin, with grease, essential oil, aromatic, tie up its life etc. be the microcapsules of the capsule heart.
U.S. Pat 5456985 is with polymer wall material such as phthalic acid ethyl cellulose, the Hydroxypropyl Methylcellulose Phathalate etc. and the composite microcapsules of making grease of non-a small amount of tolerance gastric juice wall material of tolerance gastric juice.
U.S. Pat 4849225 is the microcapsules that the wall material prepares oil soluble material with crystalline state or unbodied dehydration maltose.
European patent EP-A-0336662 prepares the fish oil micro-capsule of free from extraneous odour with ethyl cellulose, cellulose acetate phthalate etc.
Japan Patent JP-A-62201823 is with having shellac, CMC, phthalic acid methyl-propyl cellulose, phthalic acid polyvinyl alcohol to contain the microcapsules of bacterium grease for the preparation of wall material.
The WO-A-90/04391 of World Intellectual Property Organization has reported the microcapsules that fish oil are mainly EPA, DHA, is used for the treatment of intestines problem and flatulence.
In many prior arts, do not see the report of the microencapsulation that CLA and ester thereof are arranged both at home and abroad as yet.The present invention makes the microencapsulation product with CLA or conjugate linoleate by spray drying process.
Summary of the invention
The object of the invention is that the CLA developed or the microcapsules of conjugate linoleate are made up of wall material, capsule-core, auxiliary agent, surfactant, plasticizer, the capsule heart is added in the wall material aqueous solution, adding auxiliary agent, surfactant, plasticizer simultaneously carries out emulsification, and then makes microcapsules with spray drying process.This product has the following advantages through a large amount of experimental results show that:
1, strengthens its antioxygenic property, make it avoid the interference of extraneous undesirable element, improve bin stability at lay up period.
2, can shelter smell, stink.
3, can avoid mismatching in many components food the influencing each other of 5 components reduced the generation of bad change reaction.
4, can reach the purpose that control discharges.
5, be made into dry pressed powder, be easier to store, transport and add.
The CLA that the present invention developed or the microcapsules of conjugate linoleate can be used for health food, food additives and feed addictive; And have anticancer, antiatherosclerosis, regulation and control metabolism, increase muscle, reduce fat, strengthen immunity of organisms, slow down the immune system side reaction, regulate blood sugar, anti-diabetic, promote the effect of animal growth.
The microcapsules of CLA of the present invention or conjugate linoleate, these microcapsules are made up of wall material, capsule-core CLA or conjugate linoleate, auxiliary agent, surfactant, plasticizer, capsule heart CLA or conjugate linoleate are added in the wall material aqueous solution, add auxiliary agent, surfactant, plasticizer simultaneously and carry out emulsification, and then make microcapsules with spray drying process and get final product; Wherein each set of dispense ratio is: mass ratio
Wall material: capsule-core CLA or conjugate linoleate: auxiliary agent: surfactant: plasticizer 20-100: 60-100: 0.1-2: 0.1-5: 0.1-2;
The preparation method of the microcapsules of CLA or conjugate linoleate follows these steps to carry out:
A, at first prepare the wall material aqueous solution: mass ratio
With soybean protein isolate: maltodextrin 0.1-3: 1 or soybean protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or gelatin: Arabic gum 1-10: 1-10 or gelatin: Arabic gum: dextrin: soluble starch 1-10: 1-10: 1-10: 1-10 or soy bean protein hydrolysate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or carboxylated dextrin: hydroxypropyl cellulose: polyvinyl alcohol 1-10: 0.1-1: 0.1-1 or wheat flour are smart: cyclodextrin: Arabic gum: ammonia 1-10: 0.1-1: 0.1-2: 0.1-1 or cottonseed protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or peanut protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 is at 20-70 ℃, and it is that the wall material aqueous solution of 5-15% gets final product that PH=6.5-12 is mixed with concentration;
B, will capsule heart CLA or the conjugate linoleate material add in the wall material aqueous solution and stir, make that the total concentration of capsule heart CLA in the solution or conjugate linoleate material and wall materials/substances is 10-40%, the auxiliary agent, surfactant and the plasticizer that add solution gross mass 0.1-0.5% simultaneously, carry out emulsification under 30-80 ℃, the time is can obtain emulsion in 0.5-1.5 hour;
C, emulsion was disperseed 0.5-4 minute under the 10000-14000rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 1-4 time under 20-50Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, EAT 60-200 ℃, leaving air temp 30-100 ℃, charging rate 15-35ml/min can obtain the microencapsulation product.
Wherein auxiliary agent is sodium alginate or cyclodextrin; Surfactant is Span or Tween or sugar ester or polysaccharide ester or fatty acid monoglyceride; Plasticizer is glycerol triacetate or propane diols or hexadecanol;
Core material comprises: CLA or CLA methyl esters or conjugated linoleic acid ethyl ester or CLA propyl ester and C
4-C
8Ester of low-carbon alcohol or CLA glycol ester or CLA monoglyceride or CLA diglyceride or conjugated linoleic acid triglyceride or its life E ester of CLA dimension or its life C ester of CLA dimension or its life A ester or CLA stigmasterol ester or CLA sitosterol ester or CLA campesterol ester or CLA Tea Polyphenols ester of CLA dimension.
Its life E ester of CLA dimension comprises the ester of various isomers generations of α, β, γ, δ, ε, the η of CLA and VE.CLA Tea Polyphenols ester comprises the ester that generates with the various isomers of Tea Polyphenols.
The microcapsules of CLA of the present invention or conjugate linoleate, adopt water-soluble wall material, microcapsules with spray drying method for preparation CLA or conjugate linoleate, gained particle size is in the scope of 2-800 μ m, wall material thickness is at 0.2-25 μ m, and the ratio of the capsule heart in the microcapsules gross mass is in the 10-85% scope.
The specific embodiment
Embodiment 1 (mass ratio)
A, at first prepare the wall material aqueous solution:
With soybean protein isolate: maltodextrin is dissolved in 50 ℃ the 400ml water at 0.1: 1, stirs 30 minutes, and PH=7.2 is mixed with concentration and is 10% the wall material aqueous solution and gets final product;
B, will the core material CLA add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 55: 85 and to stir, make that the total concentration of core material and wall materials/substances is 25% in the solution, the auxiliary agent sodium alginate, surfactant Span and the plasticizer glycerol triacetate that add solution gross mass 0.5% simultaneously, its mass ratio is: 1: 2: 1, carry out emulsification under 60 ℃, the time is can obtain emulsion in 0.5 hour;
C, emulsion was disperseed 1 minute under the 14000rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 2 times under 40Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 190 ℃ of EATs, 85 ℃ of leaving air temps, charging rate 30ml/min can obtain microcapsule product.
Embodiment 2 (mass ratio)
A, at first prepare the wall material aqueous solution:
With soybean protein isolate: maltodextrin: xanthans takes by weighing at 2: 10: 0.1, prepare 0.4% xanthan gum solution 500ml earlier, then soybean protein isolate and maltodextrin are joined in the xanthan gum solution, 55 ℃ of water-baths were stirred 45 minutes down, regulate PH=7.4, be mixed with total concentration and be 5% the wall material aqueous solution and get final product;
B, will the core material CLA add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 24: 97 and to stir, make that the total concentration of core material and wall materials/substances is 35% in the solution, the surfactant sugar ester and the plasticizer propane diols that add solution gross mass 0.1% simultaneously, its mass ratio is: 1: 0.5, stirred 30 minutes, bath temperature is to carry out emulsification under 65 ℃, and the time is can obtain emulsion in 1.5 hours;
C, emulsion is disperseed minute 0.5 clock with disperser under the 13000rPm condition;
D, with emulsion with homogenizer homogeneous 1 time under 40Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 180 ℃ of EATs, 80 ℃ of leaving air temps, charging rate 28ml/min can obtain microcapsule product.Capsule heart content 75-80% (W/W) wherein, particle size 100-150 μ m, wall thickness 3-10 μ m.
Embodiment 3 (mass ratio)
A, at first prepare the wall material aqueous solution:
With soybean protein isolate: maltodextrin: xanthans takes by weighing at 1: 10: 0.3, elder generation is mixed with soybean protein isolate 0.5% solution 400ml, heat 55 ℃ of insulations 15 minutes, adding maltodextrin stirring back adding xanthans again stirs, 30 minutes time, PH=7.4 is mixed with concentration and is 14% the wall material aqueous solution and gets final product;
B, will the core material conjugated linoleic acid ethyl ester add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 55: 85 and to stir, make that the total concentration of core material and wall materials/substances is 35% in the solution, the surfactant Tween and the plasticizer hexadecanol that add solution gross mass 0.1% simultaneously, its mass ratio is: 3: 1, stirred 30 minutes, carry out emulsification under 65 ℃ of the temperature, the time is can obtain emulsion in 1.0 hours;
C, emulsion was disperseed 1 minute under the 12500rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 2 times under 30Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 175 ℃ of EATs, 70 ℃ of leaving air temps, charging rate 30ml/min can obtain microcapsule product.Capsule heart content 55-60% (W/W) wherein, particle size 100-150 μ m, wall thickness 5-10 μ m.
Embodiment 4 (mass ratio)
A, at first prepare the wall material aqueous solution:
With gelatin: Arabic gum: dextrin: soluble starch 1: 1: 1: 1 takes by weighing, and adds in the 400ml water, and 50 ℃ of stirring in water bath made its dissolving in 30 minutes, regulates PH=7.4, is mixed with concentration and is 5% the wall material aqueous solution and get final product;
B, will the core material conjugated linoleic acid triglyceride add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 20: 80 and to stir, make that the total concentration of core material and wall materials/substances is 25% in the solution, the surfactant Tween and the Span that add solution gross mass 0.2% simultaneously, its mass ratio is: 1: 1,75 ℃ of following stirring and emulsifying of temperature, the time is can obtain emulsion in 0.5 hour;
C, emulsion was disperseed 1 minute under the 14000rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 1 time under 30Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 185 ℃ of EATs, 50 ℃ of leaving air temps, charging rate 25ml/min can obtain microcapsule product.Capsule heart content 75-80% (W/W) wherein, particle size 180-200 μ m, wall thickness 10-20 μ m.
Embodiment 5 (mass ratio)
A, at first prepare the wall material aqueous solution:
With gelatin: Arabic gum: sodium alginate takes by weighing at 10: 10: 1, adds in the 400ml water, stirs, and at 50 ℃, it is that 10% the wall material aqueous solution gets final product that PH=6.5 is mixed with concentration;
B, will its life E ester of core material CLA dimension add in wall material aqueous solution by the mass ratio of core material and wall materials/substances 21: 63 and to stir, make that the total concentration of core material and wall materials/substances is 40% in the solution, the surfactant Span and the plasticizer hexadecanol that add solution gross mass 0.1% simultaneously, its mass ratio is: 2: 1,40 ℃ of following stirring and emulsifying of temperature, the time is can obtain emulsion in 1.5 hours;
C, emulsion was disperseed 2 minutes under the 13000rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 3 times under 35Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 150 ℃ of EATs, 80 ℃ of leaving air temps, charging rate 25ml/min can obtain microcapsule product.Capsule heart content 70% (W/W) wherein, particle size 160-180 μ m, wall thickness 5-8 μ m.
Embodiment 6 (mass ratio)
A, at first prepare the wall material aqueous solution:
With soy bean protein hydrolysate: maltodextrin: xanthans takes by weighing at 2: 10: 0.5, earlier soy bean protein hydrolysate and maltodextrin are dissolved in 50 ℃ of water of 400ml, add xanthans and stir 30 minutes time, at 50 ℃, it is that 10% the wall material aqueous solution gets final product that PH=6.5 is mixed with total concentration;
B, will its life A ester of core material CLA dimension add in wall material aqueous solution by the mass ratio of core material and wall materials/substances 63: 63 and to stir, make that the total concentration of core material and wall materials/substances is 20% in the solution, 50 ℃ of following stirring and emulsifying of temperature, the time is can obtain emulsion in 1 hour;
C, emulsion was disperseed 4 minutes under the 12500rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 2 times under 25Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 195 ℃ of EATs, 95 ℃ of leaving air temps, charging rate 30ml/min can obtain microcapsule product.Capsule heart content 50-55% (W/W) wherein, particle size 120-140 μ m, wall thickness 5-8 μ m.
Embodiment 7 (mass ratio)
A, at first prepare the wall material aqueous solution:
With the cottonseed protein isolate: maltodextrin: xanthans takes by weighing at 1.5: 15: 0.5, earlier cottonseed protein isolate and maltodextrin are dissolved in 50 ℃ of water of 400ml, add xanthans and stir 30 minutes time, at 50 ℃, it is that 5% the wall material aqueous solution gets final product that PH=7.0 is mixed with concentration;
B, will core material CLA stigmasterol ester add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 100: 100 and to stir, make that the total concentration of core material and wall materials/substances is 10% in the solution, 50 ℃ of following stirring and emulsifying of temperature, the time is can obtain emulsion in 40 minutes;
C, emulsion was disperseed 3 minutes under the 12500rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 4 times under 25Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 185 ℃ of EATs, 85 ℃ of leaving air temps, charging rate 28ml/min can obtain microcapsule product.Capsule heart content 45-50% (W/W) wherein, particle size 200-400 μ m, wall thickness 10-20 μ m.
Embodiment 8 (mass ratio)
A, at first prepare the wall material aqueous solution:
With peanut protein isolate: maltodextrin: xanthans takes by weighing at 2: 20: 1, earlier peanut protein isolate and maltodextrin are dissolved in 60 ℃ of water of 400ml, add xanthans and stir 30 minutes time, at 50 ℃, it is that 10% the wall material aqueous solution gets final product that PH=7.0 is mixed with concentration;
B, will core material CLA Tea Polyphenols ester add in the wall material aqueous solution by the mass ratio of core material and wall materials/substances 23: 69 and to stir, make that the total concentration of core material and wall materials/substances is 40% in the solution, 60 ℃ of following stirring and emulsifying of temperature, the time is can obtain emulsion in 40 minutes;
C, emulsion was disperseed 2 minutes under the 13500rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 3 times under 30Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, 190 ℃ of EATs, 75 ℃ of leaving air temps, charging rate 30ml/min can obtain microcapsule product.Capsule heart content 75-80% (W/W) wherein, particle size 300-500 μ m, wall thickness 8-18 μ m.
Claims (7)
1, the microcapsules of a kind of CLA or conjugate linoleate, it is characterized in that these microcapsules are made up of wall material, capsule-core CLA or conjugate linoleate, auxiliary agent, surfactant, plasticizer, capsule heart CLA or conjugate linoleate are added in the wall material aqueous solution, add auxiliary agent, surfactant, plasticizer simultaneously and carry out emulsification, and then make the microencapsulation product with spray drying process and get final product; Wherein each set of dispense ratio is: mass ratio
Wall material: capsule-core CLA or conjugate linoleate: auxiliary agent: surfactant: plasticizer 20-100: 60-100: 0.1-2: 0.1-5: 0.1-2;
2, the preparation method of the microcapsules of CLA according to claim 1 or conjugate linoleate is characterized in that following these steps to carrying out:
A, at first prepare the wall material aqueous solution: mass ratio
With soybean protein isolate: maltodextrin 0.1: 1-3: 1 or soybean protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or gelatin: Arabic gum 1-10: 1-10 or gelatin: Arabic gum: dextrin: soluble starch 1-10: 1-10: 1-10: 1-10 or soy bean protein hydrolysate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or carboxylated dextrin: hydroxypropyl cellulose: polyvinyl alcohol 1-10: 0.1-1: 0.1-1 or wheat flour are smart: cyclodextrin: Arabic gum: ammonia 1-10: 0.1-1: 0.1-2: 0.1-1 or cottonseed protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 or peanut protein isolate: maltodextrin: xanthans 1-2: 10-20: 0.1-1 is at 20-70 ℃, and it is that the wall material aqueous solution of 5-15% gets final product that PH=6.5-12 is mixed with concentration;
B, will capsule heart CLA or the conjugate linoleate material add in the wall material aqueous solution and stir, make that the total concentration of capsule heart CLA in the solution or conjugate linoleate material and wall materials/substances is 10-40%, the auxiliary agent, surfactant and the plasticizer that add solution gross mass 0.1-0.5% simultaneously, carry out emulsification under 30-80 ℃, the time is can obtain emulsion in 0.5-1.5 hour;
C, emulsion was disperseed 0.5-4 minute under the 10000-14000rPm condition with disperser;
D, with emulsion with homogenizer homogeneous 14 times under 20-50Mpa pressure;
E, carry out spray-drying with the emulsion of spray dryer after to homogeneous, EAT 60-200 ℃, leaving air temp 30-100 ℃, charging rate 15-35ml/min can obtain the microencapsulation product.
3, the preparation method of the microcapsules of CLA according to claim 2 or conjugate linoleate is characterized in that auxiliary agent is sodium alginate or cyclodextrin; Surfactant is Span or Tween or sugar ester or polysaccharide ester or fatty acid monoglyceride; Plasticizer is glycerol triacetate or propane diols or hexadecanol;
4, the preparation method of the microcapsules of CLA according to claim 2 or conjugate linoleate is characterized in that core material comprises: CLA or CLA methyl esters or conjugated linoleic acid ethyl ester or CLA propyl ester and C
4-C
8Ester of low-carbon alcohol or CLA glycol ester or CLA monoglyceride or CLA diglyceride or conjugated linoleic acid triglyceride or its life E ester of CLA dimension or its life C ester of CLA dimension or its life A ester or CLA stigmasterol ester or CLA sitosterol ester or CLA campesterol ester or CLA Tea Polyphenols ester of CLA dimension.
5, the preparation method of the microcapsules of CLA according to claim 4 or conjugate linoleate is characterized in that its life E ester of CLA dimension comprises the ester of various isomers generations of α, β, γ, δ, ε, the η of CLA and VE.
6, the preparation method of the microcapsules of CLA according to claim 4 or conjugate linoleate is characterized in that CLA Tea Polyphenols ester comprises the ester that generates with the various isomers of Tea Polyphenols.
7, the microcapsules of CLA according to claim 1 or conjugate linoleate are used to prepare the purposes of health food, food additives, feed addictive or cosmetics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011413905A CN1140332C (en) | 2001-10-24 | 2001-10-24 | Conjugate linoleic acid or conjugate linoleate microcapsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011413905A CN1140332C (en) | 2001-10-24 | 2001-10-24 | Conjugate linoleic acid or conjugate linoleate microcapsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1357407A CN1357407A (en) | 2002-07-10 |
| CN1140332C true CN1140332C (en) | 2004-03-03 |
Family
ID=4676133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011413905A Expired - Fee Related CN1140332C (en) | 2001-10-24 | 2001-10-24 | Conjugate linoleic acid or conjugate linoleate microcapsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1140332C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106578141A (en) * | 2016-12-20 | 2017-04-26 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid microcapsule and preparation method thereof |
| EP3821720A4 (en) * | 2018-07-13 | 2022-06-29 | Innobio Corporation Limited | Microencapsulated conjugated linoleic acid glyceride powder and preparation method thereof |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL228401B1 (en) * | 2011-05-30 | 2018-03-30 | Leenlife Polska Spolka Akcyjna | Health-promoting food agent containing ethyl esters of fatty acids especially linseed oil and process for the preparation thereof |
| CN102613577B (en) * | 2012-04-19 | 2014-03-26 | 西安海斯夫生物科技有限公司 | Water-soluble phytosterol unsaturated fatty acid microcapsule and preparation method of water-soluble phytosterol unsaturated fatty acid microcapsule |
| CN102783628B (en) * | 2012-07-10 | 2013-09-25 | 河南工业大学 | Powdered oil for replacing oil packet of instant noodles and preparation method thereof |
| CN103190630B (en) * | 2013-04-19 | 2015-08-12 | 广东太阳神集团有限公司 | A kind of functional protein powder containing conjugated linoleic acid glyceride |
| CN103238680B (en) * | 2013-05-10 | 2014-08-13 | 山东省农业科学院农产品研究所 | Walnut oil microcapsule and preparation method thereof |
| CN103284159B (en) * | 2013-06-26 | 2015-07-08 | 吉林大学 | Linoleic acid loaded soy isolate protein/chitosan composite microcapsule and preparation method thereof |
| CN103300379A (en) * | 2013-07-09 | 2013-09-18 | 天津商业大学 | Method for preparing perilla oil powder through composite condensation microencapsulation |
| CN103506058B (en) * | 2013-10-09 | 2015-05-13 | 上海理工大学 | Microcapsule spray drying device |
| CN107927326A (en) * | 2014-11-21 | 2018-04-20 | 天津天绿健科技有限公司 | A kind of feed probiotic microcapsule and its application |
| CN104472876A (en) * | 2014-12-10 | 2015-04-01 | 张家界恒兴生物科技有限公司 | Production method of special plant feed additive for aquaculture |
| CN105077249B (en) * | 2015-09-06 | 2018-03-16 | 蓬莱海洋（山东）股份有限公司 | A kind of CLA microcapsules and preparation method thereof |
| CN105747209A (en) * | 2016-02-24 | 2016-07-13 | 青岛尚医制药有限公司 | Conjugated linoleic acid micro-capsule formula and preparation method thereof |
| AU2017232554B2 (en) * | 2016-03-16 | 2020-05-14 | Golden Omega Norway As | Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production |
| CN106262924A (en) * | 2016-09-08 | 2017-01-04 | 安徽农业大学 | The spray drying preparation of 1,3 diglyceride pork fat microcapsules |
| CN106509893A (en) * | 2016-11-04 | 2017-03-22 | 无限极（中国）有限公司 | Essence oil microcapsules and preparation method thereof |
| CN107312805A (en) * | 2017-08-07 | 2017-11-03 | 中国农业大学 | A kind of preparation and its application of the polyunsaturated fatty acid rich in CLA |
| CN109645355B (en) * | 2018-12-03 | 2022-08-09 | 临沂金锣文瑞食品有限公司 | Breakfast sausage for children and preparation method thereof |
| CN113647634A (en) * | 2021-08-18 | 2021-11-16 | 南京泛成生物科技有限公司 | Vitamin K with good water solubility and stability2Microcapsule powder and preparation method thereof |
| CN115590101A (en) * | 2022-09-29 | 2023-01-13 | 精准健合（深圳）生物技术有限公司（Cn） | Coffee beverage capable of increasing fat metabolism and preparation method thereof |
-
2001
- 2001-10-24 CN CNB011413905A patent/CN1140332C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106578141A (en) * | 2016-12-20 | 2017-04-26 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid microcapsule and preparation method thereof |
| EP3821720A4 (en) * | 2018-07-13 | 2022-06-29 | Innobio Corporation Limited | Microencapsulated conjugated linoleic acid glyceride powder and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1357407A (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1140332C (en) | Conjugate linoleic acid or conjugate linoleate microcapsule | |
| CN108430461B (en) | Preparation method of high-stability microcapsule dry powder/particles containing fat-soluble nutrients with more double bonds | |
| Paramera et al. | Yeast cells and yeast-based materials for microencapsulation | |
| US20080044481A1 (en) | Microparticles for Oral Delivery | |
| JP2005500157A (en) | Coated stable microcapsule | |
| CN1731983A (en) | Microcapsules having multiple shells and method for the preparation thereof | |
| CN1612694A (en) | Encapsulation by coating with a mixture of lipids and hydrophobic, high melting point compounds | |
| CN1909960A (en) | Aqueous dispersion and its use | |
| CN1545923A (en) | Natural beta-carotene microcapsule and preparation method thereof | |
| RU2008112212A (en) | Encapsulated Active Ingredients, Methods for Their Preparation and Use | |
| EP2071919B1 (en) | Capsules | |
| CN107484985B (en) | Self-emulsifying fish oil microcapsule and production process thereof | |
| CN1747784A (en) | Complex coacervate encapsulate comprising lipophilic core | |
| WO2008020680A1 (en) | The method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule | |
| CN107836716B (en) | Algae oil microcapsule and preparation method and application thereof | |
| WO2017197453A1 (en) | Microencapsulated omega-3 polyunsaturated fatty acid glyceride compositions and processes for preparing the same | |
| JP2013240787A (en) | Large coacervated capsule | |
| CN1152739C (en) | Cyclodextrin coated conjugate linoleic acid and its derivative microcapsule | |
| CN112998273A (en) | Microemulsion and microcapsule for embedding vitamin E and algae oil and preparation method thereof | |
| CN104209072A (en) | Preparation method of corn linoleic acid microcapsules | |
| CN107805647A (en) | A kind of method of backbone ester in enzymatic clarification | |
| CN114568674B (en) | Preparation method of microcapsule with high embedding rate for powdering spice essential oil | |
| Okonkwo et al. | Application of biogels for bioactives delivery: Recent developments and future research insights | |
| CN103549635A (en) | Preparation method of resistant starch nutritional carrier based on metal-organic framework as well as product thereof | |
| CN1175926C (en) | Conjugate linoleate microcapsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |